$70,000 of DAVITA INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting health care for people living with ESRD. H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD"
You can find more data on corporate lobbying on Quiver Quantitative.
DVA Congressional Stock Trading
Members of Congress have traded $DVA stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DVA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 09/25.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
DVA Insider Trading Activity
DVA insiders have traded $DVA stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $DVA stock by insiders over the last 6 months:
- HATHAWAY INC BERKSHIRE has made 0 purchases and 10 sales selling 2,981,900 shares for an estimated $426,370,810.
- JAMES O HEARTY (Chief Compliance Officer) sold 2,351 shares for an estimated $352,650
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DVA Hedge Fund Activity
We have seen 243 institutional investors add shares of DVA stock to their portfolio, and 301 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BERKSHIRE HATHAWAY INC removed 1,345,938 shares (-3.8%) from their portfolio in Q2 2025, for an estimated $191,728,868
- PACER ADVISORS, INC. added 456,285 shares (+4437.7%) to their portfolio in Q2 2025, for an estimated $64,997,798
- HOLOCENE ADVISORS, LP removed 409,638 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $58,352,933
- EPOCH INVESTMENT PARTNERS, INC. removed 399,500 shares (-97.9%) from their portfolio in Q2 2025, for an estimated $56,908,774
- GATES CAPITAL MANAGEMENT, INC. added 376,775 shares (+52.2%) to their portfolio in Q2 2025, for an estimated $53,671,598
- IRON TRIANGLE PARTNERS LP removed 319,566 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $45,522,176
- VANGUARD GROUP INC removed 306,538 shares (-6.1%) from their portfolio in Q2 2025, for an estimated $43,666,338
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DVA Analyst Ratings
Wall Street analysts have issued reports on $DVA in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Underperform" rating on 09/10/2025
To track analyst ratings and price targets for DVA, check out Quiver Quantitative's $DVA forecast page.
DVA Price Targets
Multiple analysts have issued price targets for $DVA recently. We have seen 3 analysts offer price targets for $DVA in the last 6 months, with a median target of $149.0.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $149.0 on 10/09/2025
- Kevin Fischbeck from B of A Securities set a target price of $140.0 on 09/10/2025
- David Macdonald from Truist Securities set a target price of $164.0 on 05/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
